Harvard Bioscience, manufacturer of medical instruments, has this week bought Heka Elektronic, a software company for clinical research. From Logic-fin we wanted to analyse this sector that has so many benefits in terms of saving material resources and time and that has great advantages for researchers. You can access it here.
The use of software in medical research has a number of applications that are making researchers' jobs easier. There are already several companies that have received funding in the sector such as Caliper Life Sciences, a leading provider of cutting-edge technologies that enable researchers in the life sciences sector to develop diagnostic tests and drugs. Caliper received a $1OM round in 2010 and in 2011 was acquired by PerkinElmer.(+)
Articles about Spanish companies in medical research software .
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.
The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.
IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.
The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.
The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:
¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate? Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors? Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.
We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.
Baker Tilly Global Deal Advisory trading as Baker Tilly Global Deal Advisory is an independent member of Baker Tilly International. Baker Tilly International Limited is an English company. Baker Tilly International does not provide professional services to its clients. Each member firm is a separate and independent legal entity, and each describes itself as such. Baker Tilly Global Deal Advisory is not the agent of Baker Tilly International and does not have the authority to bind Baker Tilly International or act on behalf of Baker Tilly International. None of Baker Tilly International, Baker Tilly Global Deal Advisory, nor any of the other Baker Tilly International member firms has any liability for the acts or omissions of the others. The Baker Tilly name and associated logo is used under licence from Baker Tilly International Limited.